细胞因子和免疫球蛋白抗体在过敏性鼻炎小鼠早期无症状阶段和晚期有症状阶段表达的差异

doi:10.3969/j.issn.1006-7795.2018.01.012

首都医科大学学报 ›› 2018, Vol. 39 ›› Issue (1): 63-68.doi: 10.3969/j.issn.1006-7795.2018.01.012

• 鼻炎和鼻窦炎的基础研究 • 上一篇下一篇

细胞因子和免疫球蛋白抗体在过敏性鼻炎小鼠早期无症状阶段和晚期有症状阶段表达的差异

杨军¹, 王敏¹, 张罗^1,2

1. 首都医科大学附属北京同仁医院耳鼻咽喉头颈外科北京市耳鼻咽喉科研究所教育部耳鼻咽喉头颈科学重点实验室鼻病研究北京市重点实验室, 北京 100730;
2. 首都医科大学附属北京同仁医院鼻过敏科, 北京 100730

收稿日期:2017-12-11 出版日期:2018-01-21 发布日期:2018-01-27
通讯作者: 张罗 E-mail:dr.luozhang@139.com
基金资助:
国家自然科学基金重点国际合作项目（81420108009），国家自然科学基金重点项目（81630023），国家自然科学基金面上项目（81570893），教育部长江学者和创新团队发展计划（IRT13082），北京市百千万人才工程资助项目（2016），北京市自然科学基金面上项目（7162042），首都卫生发展科研专项项目（首发2014-4-1092），北京市卫生系统高层次卫生技术人才（2009-2-007，2011-3-043，2014-3-018），北京市医院管理局使命人才计划（SML20150203），北京市科技项目统筹课题（Z171100000117002）。

Expression of cytokines and immunoglobulin antibodies in the early asymptomatic and late symptomatic stage of allergic rhinitis mouse model

Yang Jun¹, Wang Min¹, Zhang Luo^1,2

1. Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing Institute of Otorhinolaryngology, Key Laboratory of Otorhinolaryngology Head and Neck Surgery, Ministry of Education, Beijing Key Laboratory of Nasal Diseases, Beijing 100730, China;
2. Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China

Received:2017-12-11 Online:2018-01-21 Published:2018-01-27
Supported by:
This study was supported by National Natural Science Foundation of China (81420108009, 81630023, 81570893),Changjiang Scholars and Innovative Research Team (IRT13082), Beijing Talent Project (2016), Natural Science Foundation of Beijing (7162042), Capital Special Projects for Scientific Research on Health Development(2014-4-1092),Beijing Health Bureau Program for High Level Talents (2009-2-007, 2011-3-043, 2014-3-018), Beijing Municipal Administration of Hospitals' Mission Plan (SML20150203), Beijing Scientific and Technological Overall Plan (Z171100000117002).

摘要/Abstract

摘要： 目的探讨白细胞介素（interleukin-4，IL-4），IL-17，IL-6和免疫球蛋白抗体在过敏性鼻炎（allergic rhinitis，AR）早期无症状阶段的表达及与过敏症状的关系。方法建立卵清蛋白（ovalbumin，OVA）诱导的AR小鼠模型，在激发早期（第16天）和激发晚期（第30天）观察鼻部症状，收集鼻黏膜检测干扰素-γ（interferon-γ，IFN-γ）、IL-4、IL-17和IL-6基因表达，收集血清检测IgE、IgG1、IgG2a抗体和IFN-γ、IL-4、IL-17和IL-6蛋白表达水平。结果挠鼻和喷嚏的次数在激发晚期显著高于激发早期和对照组，而在激发早期与对照组比较，差异无统计学意义（P>0.05）。OVA-特异性IgE抗体在AR激发早期和晚期小鼠均显著高于对照组，但两组间差异无统计学意义（P>0.05）。OVA-特异性IgG1和IgG2a抗体、鼻黏膜IL-17和IL-6基因表达及血清IL-17和IL-6蛋白表达有相似趋势，即在AR激发早期和激发晚期阶段均显著高于对照组，且在激发晚期阶段显著高于激发早期阶段。鼻黏膜IL-4基因和血清IL-4蛋白水平在激发晚期阶段显著高于对照组。结论 IL-17、IL-6、过敏原特异性IgG1和IgG2a可能参与了AR早期无症状阶段的反应，且其表达水平可能与过敏症状的出现有关。

关键词: 过敏性鼻炎, 过敏症状, 免疫球蛋白抗体, 白细胞介素-17, 白细胞介素-6

Abstract: Objective To investigate the expression of interleukin-4 (IL-4), IL-17, IL-6 and immunoglobulin antibodies in early stage of allergic rhinitis (AR) response and their association with allergic symptoms.Methods At early stage (day 16) and late stage (day 30) of ovalbumin (OVA)-induced allergic rhinitis (AR) mouse model, nasal symptoms were measured; nasal mucosa was collected to detect the gene expression of interferon-γ(IFN-γ), IL-4, IL-17 and IL-6; serum was collected to detect the levels of OVA-specific IgE, IgG1, IgG2a and protein expression of IFN-γ, IL-4, IL-17 and IL-6.Results The number of nasal rubbings and sneezes was increased significantly in late stage compared to early stage and control, and had no significant difference between early stage and control. The level of serum OVA-specific IgE was significantly higher in early stage and late stage than that in control, but has no significant difference between early stage and late stage. Serum OVA-specific IgG1and IgG2a, gene expression of IL-17 and IL-6 in nasal mucosa, and serum IL-17 and IL-6 protein had similar expression patterns. These variables were significantly higher in early stage and late stage than those in control, and significantly higher in late stage than those in early stage. Gene expression of IL-4 in nasal mucosa and serum IL-4 protein levels in late stage was significantly higher than those in control.Conclusion IL-17, IL-6, and allergen specific IgG1 and IgG2a may be involved in the early stage of host against allergen response, and their levels may be associated with allergic symptoms.

Key words: allergic rhinitis, allergic symptoms, immunoglobulin antibodies, interleukin-17(IL-17), interleukin-6(IL-6)

中图分类号:

R765.21

杨军, 王敏, 张罗. 细胞因子和免疫球蛋白抗体在过敏性鼻炎小鼠早期无症状阶段和晚期有症状阶段表达的差异[J]. 首都医科大学学报, 2018, 39(1): 63-68.

Yang Jun, Wang Min, Zhang Luo. Expression of cytokines and immunoglobulin antibodies in the early asymptomatic and late symptomatic stage of allergic rhinitis mouse model[J]. Journal of Capital Medical University, 2018, 39(1): 63-68.

参考文献

[1] Bousquet J, Khaltaev N, Cruz A A,et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)[J].Allergy, 2008,63(Suppl 86):8-160.
[2] Wang X D, Zheng M, Lou H F,et al. An increased prevalence of self-reported allergic rhinitis in major chinese cities from 2005 to 2011[J]. Allergy, 2016,71(8):1170-1180.
[3] Hansen I, Klimek L, Mösges R, et al. Mediators of inflammation in the early and the late phase of allergic rhinitis[J]. Curr Opin Allergy Clin Immunol, 2004,4(3):159-163.
[4] Dullaers M, De Bruyne R, Ramadani F, et al. The who, where, and when of IgE in allergic airway disease[J]. J Allergy Clin Immunol,2012,129(3):635-645.
[5] Cho K S, Park H K, Park H Y, et al. IFATS collection:Immunomodulatory effects of adipose tissue-derived stem cells in an allergic rhinitis mouse model[J]. Stem Cells, 2009,27(1):259-265.
[6] Semik-Orzech A, Barczyk A, Wiaderkiewicz R, et al. Interleukin 17 and RANTES levels in induced sputum of patients with allergic rhinitis after a single nasal allergen challenge[J]. Ann Allergy Asthma Immunol, 2009,103(5):418-424.
[7] Ciprandi G, Fenoglio D, De Amici M, et al. Serum IL-17 levels in patients with allergic rhinitis[J]. J Allergy Clin Immunol, 2008,122(3):650-651.e2.
[8] Ciprandi G, De Amici M, Murdaca G, et al. Serum interleukin-17 levels are related to clinical severity in allergic rhinitis[J]. Allergy, 2009,64(9):1375-1378.
[9] Petti F B,Liguori A, Ippoliti F. Study on cytokines IL-2, IL-6, IL-10 in patients of chronic allergic rhinitis treated with acupuncture[J]. J Tradit Chin Med, 2002,22(2):104-111.
[10] Hsueh K C, Lin C Y, Lin Y J. Serum levels of resistin in allergic rhinitis and its relationship with disease severity[J]. Am J Rhinol Allergy, 2009,23(4):365-369.
[11] Wang M, Zhang W, Shang J, et al.Immunomodulatory effects of IL-23 and IL-17 in a mouse model of allergic rhinitis[J]. Clin Exp Allergy, 2013,43(8):956-966.
[12] Galli S J, Tsai M, Piliponsky A M. The development of allergic inflammation[J]. Nature, 2008,454(7203):445-454.
[13] Bousquet J, Anto J M, Bachert C, et al. Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project[J].Allergy,2006,61(6):671-680.
[14] Iwakura Y, Ishigame H, Saijo S, et al. Functional specialization of interleukin-17 family members[J]. Immunity, 2011,34(2):149-162.
[15] Braunstahl G J, Fokkens W J, Overbeek S E, et al. Mucosal and systemic inflammatory changes in allergic rhinitis and asthma:a comparison between upper and lower airways[J]. Clin Exp Allergy, 2003,33(5):579-587.
[16] Burgler S, Ouaked N, Bassin C, et al. Differentiation and functional analysis of human T(H)17 cells[J]. J Allergy Clin Immunol, 2009,123(3):588-595, 595.e1-7.
[17] 马思琪, 闫宇,佟凤娇,等.白细胞介素-17A诱导脂肪细胞中炎症因子表达[J].中国煤炭工业医学杂志,2017,20(2):186-189.

细胞因子和免疫球蛋白抗体在过敏性鼻炎小鼠早期无症状阶段和晚期有症状阶段表达的差异

Expression of cytokines and immunoglobulin antibodies in the early asymptomatic and late symptomatic stage of allergic rhinitis mouse model

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	张心红, 杨楚琪, 王轩, 沈霞光, 房纯, 王凤英. 白细胞介素-6和超敏C反应蛋白与围产期颅内静脉窦血栓的相关性研究[J]. 首都医科大学学报, 2021, 42(2): 210-213.
[2]	翟春艳, 底婷婷, 赵京霞, 王燕, 解欣然, 李雪, 蒙玉娇, 李宁飞, 刘正荣, 张璐, 张蕾, 王宁, 李萍. 解毒药与凉血药配伍对咪喹莫特诱导的银屑病样小鼠模型的干预作用[J]. 首都医科大学学报, 2018, 39(2): 243-251.
[3]	李景云, 张媛, 张罗. NOS2基因单核苷酸多态性与单纯尘螨过敏性鼻炎相关性研究[J]. 首都医科大学学报, 2018, 39(1): 51-56.
[4]	娄鸿飞, 马思远, 赵岩, 曹飞飞, 贺飞, 王向东, 王成硕, 张罗. 京津冀地区自报过敏性鼻炎病人吸入过敏原检测临床相关性分析[J]. 首都医科大学学报, 2017, 38(5): 665-670.
[5]	马思远, 娄鸿飞, 王成硕, 张罗. 北京地区可疑过敏性鼻炎病人吸入性变应原特征分析[J]. 首都医科大学学报, 2017, 38(5): 671-676.
[6]	赵延明, 王成硕, 赵亚丽, 张媛, 张罗. 人类白细胞抗原Ⅱ类基因多态性与中国人群尘螨过敏性鼻炎相关性研究[J]. 首都医科大学学报, 2017, 38(5): 688-694.
[7]	赵亚丽, 张媛, 王成硕, 张罗. 白细胞介素-6受体基因非同义变异rs2228145和中国过敏性鼻炎病人的相关性研究[J]. 首都医科大学学报, 2017, 38(5): 695-699.
[8]	林梅, 张冬雪, 刘志强, 王左敏. 慢性牙周炎患者血清IL-33、TNF-α、IL-6的检测及意义[J]. 首都医科大学学报, 2016, 37(3): 255-259.
[9]	王敏, 杨军, 尚军, 张罗. 肿瘤坏死因子α诱导蛋白2在过敏性鼻炎小鼠模型中的表达及与血管生成的关系[J]. 首都医科大学学报, 2013, 34(6): 790-794.
[10]	赵延明, 张罗. 过敏性鼻炎的遗传学研究进展[J]. 首都医科大学学报, 2013, 34(6): 808-813.
[11]	张媛;刘承耀;段甦;赵延明;张罗. 过敏性鼻炎皮肤点刺试验阳性界值对血清特异性IgE诊断价值的影响[J]. 首都医科大学学报, 2011, 32(6): 717-720.
[12]	刘洁;王泳;武连华;高春锦. 高压氧预处理对小鼠低氧耐受能力的影响[J]. 首都医科大学学报, 2011, 32(5): 670-673.
[13]	段甦;张媛;张罗. 过敏性疾病的自然进程及干预[J]. 首都医科大学学报, 2011, 32(1): 55-59.
[14]	杨酉;刘仲燕;韩德民;张罗. 非过敏性鼻炎伴嗜酸性粒细胞增多综合征患者的鼻通气功能评估[J]. 首都医科大学学报, 2011, 32(1): 26-31.
[15]	张媛;赵延明;贺飞;张罗. 儿童过敏性鼻炎的吸入性过敏原[J]. 首都医科大学学报, 2011, 32(1): 13-16.